Tsuyoshi Imaizumi1, Shinju Obara2, Midori Mogami3, Yuzo Iseki1, Makiko Hasegawa3, Masahiro Murakawa3. 1. Department of Intensive Care Medicine, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. 2. Surgical Operation Department, Fukushima Medical University Hospital, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan. obashin99@gmail.com. 3. Department of Anesthesiology, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima, Fukushima, 960-1295, Japan.
Abstract
INTRODUCTION: Intravenous (i.v.) acetaminophen is administered during surgery for postoperative analgesia. However, little information is available on the pharmacokinetics of i.v. acetaminophen in Japanese patients undergoing surgery under general anesthesia. METHODS: The study was approved by the Institutional Review Board and registered at UMIN-CTR (UMIN000013418). Patients scheduled to undergo elective surgery under general anesthesia were enrolled after obtaining written informed consent. During surgery, 1 g of i.v. acetaminophen was administered over 15, 60, or 120 min. Acetaminophen concentrations (15 or 16 samples per case) were measured at time points from 0-480 min after the start of administration (liquid chromatography-mass spectrometry/tandem mass spectrometry; limit of quantitation 0.1 μg/mL). The predictive performance of three published pharmacokinetic models was evaluated. Population pharmacokinetics were also analyzed using a nonlinear mixed-effect model based on the NONMEM program. RESULTS: Data from 12 patients who underwent endoscopic or lower limb procedures were analyzed (male/female = 7/5, median age 55 years, weight 63 kg). Anesthesia was maintained with remifentanil and propofol or sevoflurane. The pharmacokinetic model of i.v. acetaminophen reported by Würthwein et al. worked well. Using 185 datapoints, the pharmacokinetics of i.v. acetaminophen were described by a two-compartment model with weight as a covariate but not age, sex, or creatinine clearance. The median prediction error and median absolute prediction error of the final model were -1 and 10%, respectively. CONCLUSION: A population pharmacokinetic model of i.v. acetaminophen in Japanese patients was constructed, with performance within acceptable ranges.
RCT Entities:
INTRODUCTION: Intravenous (i.v.) acetaminophen is administered during surgery for postoperative analgesia. However, little information is available on the pharmacokinetics of i.v. acetaminophen in Japanese patients undergoing surgery under general anesthesia. METHODS: The study was approved by the Institutional Review Board and registered at UMIN-CTR (UMIN000013418). Patients scheduled to undergo elective surgery under general anesthesia were enrolled after obtaining written informed consent. During surgery, 1 g of i.v. acetaminophen was administered over 15, 60, or 120 min. Acetaminophen concentrations (15 or 16 samples per case) were measured at time points from 0-480 min after the start of administration (liquid chromatography-mass spectrometry/tandem mass spectrometry; limit of quantitation 0.1 μg/mL). The predictive performance of three published pharmacokinetic models was evaluated. Population pharmacokinetics were also analyzed using a nonlinear mixed-effect model based on the NONMEM program. RESULTS: Data from 12 patients who underwent endoscopic or lower limb procedures were analyzed (male/female = 7/5, median age 55 years, weight 63 kg). Anesthesia was maintained with remifentanil and propofol or sevoflurane. The pharmacokinetic model of i.v. acetaminophen reported by Würthwein et al. worked well. Using 185 datapoints, the pharmacokinetics of i.v. acetaminophen were described by a two-compartment model with weight as a covariate but not age, sex, or creatinine clearance. The median prediction error and median absolute prediction error of the final model were -1 and 10%, respectively. CONCLUSION: A population pharmacokinetic model of i.v. acetaminophen in Japanese patients was constructed, with performance within acceptable ranges.
Entities:
Keywords:
Intravenous acetaminophen; Pharmacokinetics; Population
Authors: Kenichi Masui; Richard N Upton; Anthony G Doufas; Johan F Coetzee; Tomiei Kazama; Eric P Mortier; Michel M R F Struys Journal: Anesth Analg Date: 2009-10-27 Impact factor: 5.108
Authors: Katie H Owens; Natalie J Medlicott; Mathew Zacharias; Neil Curran; Sree Chary; Mark Thompson-Fawcett; David M Reith Journal: Ther Drug Monit Date: 2012-12 Impact factor: 3.681
Authors: Katie H Owens; Philip G M Murphy; Natalie J Medlicott; Julia Kennedy; Mathew Zacharias; Neil Curran; Sree Sreebhavan; Mark Thompson-Fawcett; David M Reith Journal: J Pharmacokinet Pharmacodyn Date: 2014-05-21 Impact factor: 2.745
Authors: Gudrun Würthwein; Susanne Koling; Alexander Reich; Georg Hempel; Petra Schulze-Westhoff; Paulo V Pinheiro; Joachim Boos Journal: Eur J Clin Pharmacol Date: 2005-01-21 Impact factor: 2.953
Authors: Neil K Singla; Cherri Parulan; Roselle Samson; Joel Hutchinson; Rick Bushnell; Evelyn G Beja; Robert Ang; Mike A Royal Journal: Pain Pract Date: 2012-04-24 Impact factor: 3.183
Authors: Antti Liukas; Kristiina Kuusniemi; Riku Aantaa; Petri Virolainen; Mikko Niemi; Pertti J Neuvonen; Klaus T Olkkola Journal: Clin Pharmacokinet Date: 2011-02 Impact factor: 6.447
Authors: Chenguang Wang; Karel Allegaert; Dick Tibboel; Meindert Danhof; Caroline D van der Marel; Ron A A Mathot; Catherijne A J Knibbe Journal: J Clin Pharmacol Date: 2014-01-23 Impact factor: 3.126